Formation Bio Email Format
Biotechnology ResearchNew York, United States201-500 Employees
Formation Bio operates in the biotechnology sector with an AI-driven approach to drug development. It has built proprietary platforms designed to optimize critical aspects of clinical programs, aiming for faster trial execution and higher-quality data. The company acquires clinical-stage drugs from pharmaceutical and biotech partners to advance assets more quickly and extract greater value per program. Its customers are pharma and biotech organizations seeking to accelerate development timelines and improve outcomes across clinical trials. Based in New York, New York, the business is described as a mid-sized player in biotech research. In 2025, it added Mikael Dolsten as a strategic advisor, reflecting ongoing efforts to strengthen its scientific leadership.